Triazavirin

Triazavirin is an antiviral drug that was developed by the Ural Branch of the Russian Academy of Sciences. It is primarily used for the treatment of influenza viruses and other acute respiratory viral infections. The drug has also been used in the treatment of Hantavirus infections and Crimean-Congo hemorrhagic fever.

History

Triazavirin was first synthesized in 1990 by a team of chemists at the Ural Branch of the Russian Academy of Sciences. The drug was later patented in 1996 and has since been used in the treatment of various viral infections.

Mechanism of Action

Triazavirin works by inhibiting the replication of the viral RNA. It does this by interfering with the viral RNA polymerase, an enzyme that is necessary for the replication of the virus. This prevents the virus from multiplying and spreading throughout the body.

Uses

Triazavirin is primarily used in the treatment of influenza viruses and other acute respiratory viral infections. It has also been used in the treatment of Hantavirus infections and Crimean-Congo hemorrhagic fever.

Side Effects

Like all drugs, Triazavirin can cause side effects. These can include nausea, vomiting, and diarrhea. In rare cases, it can also cause more serious side effects such as anemia and leukopenia.

See Also

• Antiviral drug
• Influenza
• Hantavirus
• Crimean-Congo hemorrhagic fever

Triazavirin Resources
Latest articles Most recent articles Ongoing trials	Wikipedia